BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15538750)

  • 1. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
    Koch A; Denkhaus D; Albrecht S; Leuschner I; von Schweinitz D; Pietsch T
    Cancer Res; 1999 Jan; 59(2):269-73. PubMed ID: 9927029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
    Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
    Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
    Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
    Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
    Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
    Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
    Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
    BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
    Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
    Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
    Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
    Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
    Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I
    Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer and genetic alterations in the Wnt pathway.
    Segditsas S; Tomlinson I
    Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
    Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
    Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
    D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
    Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.